Design, synthesis and biological evaluation of a novel series of potent, orally active adenosine A1 receptor antagonists with high blood-brain barrier permeability.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Chemical and pharmaceutical bulletin

• Publication date

  2001-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/CPB.49.988PMID 11515591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel adenosine A1 receptor antagonists. Synthesis and structure-activity relationships of a novel series of 3-(2-cyclohexenyl-3-oxo-2,3-dihydropyridazin-6-yl)-2-phenylpyrazolo[1,5 -a]pyridines.

  2000cited by this paper
• Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.

  1999cited by this paper
• Synthesis of the water-soluble adenosine A1 receptor antagonist FR166124 through a novel sequential Horner-Emmons / isomerization reaction

  1999cited by this paper
• Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist.

  1999cited by this paper
• Pilot-Scale Synthesis of a Novel Non-Xanthine Adenosine A1 Receptor Antagonist. 1,3-Dipolar Cycloaddition of Pyridine N-Imine to an Acetylene

  1998cited by this paper
• Adenosine receptors: new opportunities for future drugs.

  1998cited by this paper
• Cytochromes P450 Metabolic and Toxicological Aspects

  1996cited by this paper
• Adenosine receptors.

  1995cited by this paper
• Transport of small molecules through the blood-brain barrier: biology and methodology.

  1995cited by this paper
• Effects of adenosine receptor agonists and antagonists on acquisition of passive avoidance learning.

  1994cited by this paper
• Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study.

  1993cited by this paper
• Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.

  1993cited by this paper
• Adenosine receptor subtypes.

  1993cited by this paper
• Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

  1992cited by this paper
• 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.

  1990cited by this paper
• Pyridazinones. 2. Synthesis and antisecretory and antiulcer activities of thiourea and 2-cyanoguanidine derivatives.

  1983cited by this paper
• The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products

  1981cited by this paper
• Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reduction.

  1974cited by this paper

• Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease.

  2020cites this paper
• PET Imaging of Adenosine Receptors in Diseases.

  2019cites this paper
• Restoring auditory cortex plasticity in adult mice by restricting thalamic adenosine signaling

  2017cites this paper
• Rejuvenating brain plasticity

  2017cites this paper
• Synthesis of N-(2-(Methylamino)ethyl) Derivatives of 2H-Phthalazin-1-ones

  2014cites this paper
• Affinity of dihydropyrimidone analogues for adenosine A1 and A2A receptors

  2014cites this paper
• Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV.

  2014cites this paper
• Biopharmaceutical characterization of decursin and their derivatives for drug discovery

  2013cites this paper
• Adenosine in the inflamed gut: a Janus faced compound.

  2011cites this paper
• Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.

  2010cites this paper
• Adenosine receptor ligands and PET imaging of the CNS.

  2009influential citation
• Synthesis and Pharmacological Evaluation of N‐(Dimethylamino)ethyl Derivatives of Benzo‐ and Pyridopyridazinones

  2009cites this paper
• Molecular design of pyrazolo[3,4-d]pyridazines

  2008cites this paper
• Concise routes to pyrazolo[1,5-a]pyridin-3-yl pyridazin-3-ones.

  2008cites this paper
• Structure-brain exposure relationships.

  2006cites this paper
• Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists.

  2006cites this paper
• Progress in the pursuit of therapeutic adenosine receptor antagonists

  2006cites this paper
• A recursive-partitioning model for blood–brain barrier permeation

  2005cites this paper
• Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.

  2005cites this paper
• A Practical Approach for Preparation of 2‐[(Dialkylamino)‐methyl]‐4‐aryl‐2H‐phthalazin‐1‐ones via Mannich Reaction of 4‐Aryl‐2H‐phthalazin‐1‐ones

  2005cites this paper
• Non‐Xanthine Antagonists for the Adenosine A1 Receptor

  2004cites this paper
• "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities.

  2004cites this paper
• Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors.

  2004cites this paper
• Medicinal chemistry of adenosine A1 receptor ligands.

  2003cites this paper
• Design, Synthesis and Biological Evaluation of a Novel Series of Potent, Orally Active Adenosine A1 Receptor Antagonists with High Blood—Brain Barrier Permeability.

  2002cites this paper
• Monitor: molecules and profiles.

  2001cites this paper
• Monitor: molecules and profiles.

  2001cites this paper